Literature DB >> 3027565

Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

U Müller, C V Jongeneel, S A Nedospasov, K F Lindahl, M Steinmetz.   

Abstract

Tumour necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are related proteins, secreted by macrophages and lymphocytes respectively, which play a role in destruction of tumour cells and virally infected cells (for reviews see refs 1,2). TNF-alpha is a non-glycosylated protein of relative molecular mass 17,000 (Mr 17 K), whereas TNF-beta is a glycoprotein of Mr 25 K. Both TNF-alpha and TNF-beta aggregate into multimers and act through the same receptor molecule on target cells. Genes encoding these two TNF proteins have been cloned from mouse and man and in both are closely linked, being separated by approximately 1 kilobase (kb) of DNA. In the mouse these genes are located on chromosome 17, but in man they are on the short arm of chromosome 6. This segment of chromosome 6 also contains the genes of the major histocompatibility complex (MHC), as does chromosome 17 in the mouse. To find out whether the TNF genes are located within the MHC, we used polymorphic restriction sites to analyse a panel of MHC congeneic and intra-MHC recombinant mouse strains. Initially, we mapped the TNF genes the D or Qa region in the distal half of the mouse MHC. We then studied a gene cluster encompassing part of the D and Qa regions and found the TNF genes are located 70 kb proximal to the D gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027565     DOI: 10.1038/325265a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  64 in total

1.  Sequence of the tumor necrosis factor/cachectin (TNF) gene from Peromyscus leucopus (family Cricetidae).

Authors:  M D Crew; M E Filipowsky
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Mouse chromosome 17.

Authors:  L M Silver; K Artzt; D Barlow; K Fischer-Lindahl; M F Lyon; J Klein; L Snyder
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  The B144-H-2Db interval and the location of a mouse homologue of the human D6S81E locus.

Authors:  J M Wroblewski; S G Kaminsky; V K Milisauskas; A M Pittman; D D Chaplin; T Spies; I Nakamura
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

Authors:  M B Alimzhanov; D V Kuprash; M H Kosco-Vilbois; A Luz; R L Turetskaya; A Tarakhovsky; K Rajewsky; S A Nedospasov; K Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 5.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

6.  Fine mapping of the crossover-sites in the C4-H-2D region of H-2 recombinant mouse strains.

Authors:  M Snoek; P C Groot; T Spies; R D Campbell; P Demant
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Characterization of several new MHC congenic strains.

Authors:  A C Walsh; J Slack; L Flaherty
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

8.  A cluster of transcribed sequences between the Pb and Ob genes of the murine major histocompatibility complex.

Authors:  S Cho; M Attaya; M G Brown; J J Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

9.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor.

Authors:  M Jasiński; J Wieckiewicz; I Ruggiero; A Pituch-Noworolska; M Zembala
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.